[{"notes_id":"1_667","category":"3","subcategory":"1","title":"Hypoglycaemia","body":"Causes<br \/><ul><li>insulinoma - increased ratio of proinsulin to insulin<\/li><li>self-administration of insulin\/sulphonylureas<\/li><li>liver failure<\/li><li>Addison's disease<\/li><li><span class=\"concept\" data-cid=\"11800\">alcohol<\/span><ul><li>causes exaggerated insulin secretion<\/li><li>mechanism is thought to be due to the effect of alcohol on the pancreatic microcirculation &rarr; redistribution of pancreatic blood flow from the exocrine into the endocrine parts &rarr; increased insulin secretion<\/li><\/ul><\/li><li>nesidioblastosis - beta cell hyperplasia<\/li><\/ul><br \/>Physiological response to hypoglycaemia<br \/><ul><li>hormonal response: the first response of the body is decreased insulin secretion. This is followed by <span class=\"concept\" data-cid=\"9918\">increased glucagon secretion<\/span>. Growth hormone and cortisol are also released but later<\/li><li>sympathoadrenal response: increased catecholamine-mediated (adrenergic) and acetylcholine-mediated (cholinergic) neurotransmission in the peripheral autonomic nervous system and in the central nervous system<\/li><\/ul><br \/>Features<br \/><ul><li>blood glucose levels and the severity of symptoms are not always correlated, especially in patients with diabetes.<\/li><li>blood glucose concentrations <3.3 mmol\/L cause autonomic symptoms due to the release of glucagon and adrenaline (average frequency in brackets):<ul><li>Sweating<\/li><li>Shaking <\/li><li>Hunger<\/li><li>Anxiety<\/li><li>Nausea<\/li><\/ul><\/li><li>blood glucose concentrations below <2.8 mmol\/L cause neuroglycopenic symptoms due to inadequate glucose supply to the brain:<ul><li>Weakness <\/li><li>Vision changes<\/li><li>Confusion <\/li><li>Dizziness<\/li><\/ul><\/li><li>Severe and uncommon features of hypoglycaemia include:<ul><li>Convulsion<\/li><li>Coma<\/li><\/ul><\/li><\/ul><br \/>Investigation of hypoglycaemia<br \/><ul><li>if the cause of hypoglycaemia is not clear then a combination of serum insulin and c-peptide levels can be measured<\/li><li>remember that insulin and C-peptide are released in equimolar amounts from the pancreas, making C-peptide a marker of endogenous insulin production.<\/li><\/ul><br \/><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th>Insulin Level<\/th><th>\tC-peptide Level<\/th><th>\tInterpretation<\/th><th>\tPotential Causes<\/th><\/tr><\/thead><tbody><tr><td>High\t<\/td><td>High\t<\/td><td><span class=\"concept\" data-cid=\"12274\">Endogenous insulin production<\/span><\/td><td>\tInsulinoma, Sulfonylurea use\/abuse<\/td><\/tr><tr><td>High<\/td><td>\tLow\t<\/td><td><span class=\"concept\" data-cid=\"12275\">Exogenous insulin administration<\/span>\t<\/td><td>Exogenous insulin overdose, Factitious disorder<\/td><\/tr><tr><td>Low<\/td><td>\tLow\t<\/td><td>Non-insulin-related cause<\/td><td>Alcohol-induced hypoglycaemia, Critical illness (e.g., sepsis), Adrenal insufficiency, Growth hormone deficiency, Fasting\/starvation<\/td><\/tr><\/tbody><\/table><\/div><br \/>Management of hypoglycaemia<br \/><ul><li>the following guidelines are based on the BNF hypoglycaemia treatment summary.<\/li><li>in the community (for example, diabetes mellitus patients who inject insulin):<ul><li><span class=\"concept\" data-cid=\"11441\">Initially, oral glucose 10-20g should be given in liquid, gel or tablet form<\/span><\/li><li>Alternatively, a propriety quick-acting carbohydrate may be given: GlucoGel or Dextrogel.<\/li><li>A 'HypoKit' may be prescribed which contains a syringe and vial of glucagon for IM or SC injection at home<\/li><\/ul><\/li><li>in a hospital setting:<ul><li><span class=\"concept\" data-cid=\"11441\">If the patient is alert, a quick-acting carbohydrate may be given (as above)<\/span><\/li><li>If the patient is unconscious or unable to swallow, subcutaneous or intramuscular injection glucagon may be given.<\/li><li>Alternatively, intravenous 20% glucose solution may be given through a large vein<\/li><\/ul><\/li><\/ul>","notes_hash":"e2c6961bddebf47515f17b04aa798c7d","knowledge_graph_node_id_link":1237,"links":"","media":"","concepts_for_notes":{"11441":{"concept_text":"Hypoglycaemia treatment - if the patient is conscious and able to swallow the first-line treatment is a fast-acting carbohydrate by mouth i.e..  glucose liquids, tablets or gels","concept_percentile":"40"}},"category_name":"Endocrinology \/ Metabolic","subcategory_name":"Endocrinology","comment_count":12},"",[]]